Skip to main content

Community Oncology and Prevention Trials

Supports clinical oncology trials in cancer prevention and control in community settings. Funds investigator-initiated research in supportive, palliative and end-of-life care. Coordinates with other NCI programs to conduct clinical oncology research projects in the community setting.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048	5E334	Chief \| Breast and Gynecologic Cancer Acting Chief \| Community Oncology and Prevention Trials
	Lee, Beverly beverly.lee@nih.gov	5E532	Program Officer \| Community Oncology and Prevention Trials
	Lee, Cecilia, Dr.P.H., RN cecilia.lee@nih.gov 240-276-7152	5E516	Nurse Consultant \| Community Oncology and Prevention Trials
	Maxwell, Pamela pamela.maxwell@nih.gov 240-276-7081	5E434	Program Specialist \| Community Oncology and Prevention Trials
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Parker, Bernard, M.D., FACP bernard.parker@nih.gov 240-276-5533	5E448	Program Officer \| Community Oncology and Prevention Trials
	Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050	5E430	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163	5E524	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	Whitman, Cynthia, B.S. [C] cynthia.whitman@nih.gov		Contractor \| Community Oncology and Prevention Trials

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Wolpin, Brian Matthew	Dana-Farber Cancer Inst United States	Altered metabolism and machine learning for pancreatic cancer early detection	5U01CA210171-09	Matthew Young, Ph.D.
Wong, David T	University Of California Los Angeles United States	EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment	4U01CA233370-08	Nicholas Hodges, Ph.D.
Wright, Alexi A	Dana-Farber Cancer Inst United States	Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors	5R01CA289547-02	Goli Samimi, Ph.D., M.P.H.
Wu, Yun	State University Of New York At Buffalo United States	Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay	4R01CA272827-04	Christos Patriotis, Ph.D., M.Sc.
Xiao, Yi	University Of Tx Md Anderson Can Ctr United States	Exploring new strategy for breast cancer immunoprevention by targeting histamine receptor H1	5R21CA286318-02	Anda Vlad, M.D., Ph.D.
Xu, Xiangxi Mike	University Of Miami School Of Medicine United States	Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy	5R01CA286527-02	Rachel Altshuler, Ph.D.
Xu, Chunhui	Emory University United States	High-throughput assessment of chemotherapy-induced cardiotoxicity in 3D human cardiomyocytes	1R21CA285254-01A1	Eileen Dimond, R.N., M.S.
Yaddanapudi, Kavitha	University Of Louisville United States	A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer	5R21CA277314-02
Yaghjyan, Lusine	University Of Florida United States	Stromal contributions to breast carcinogenesis	5R01CA277817-03	Christos Patriotis, Ph.D., M.Sc.
Yang, Qing	University Of Texas Med Br Galveston United States	The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy	5R01CA273001-02	Rachel Altshuler, Ph.D.
Yang, Wan	Columbia University Health Sciences United States	UNCOVER: underlying novel causes of onset of very early cancer research	5R01CA257971-05	Nicholas Hodges, Ph.D.
Yeh, Jennifer M.	Boston Children'S Hospital United States	Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care	5R01CA261874-04	Eileen Dimond, R.N., M.S.
Yendamuri, Saikrishna	Roswell Park Cancer Institute Corp United States	Metformin for chemoprevention of lung cancer in obese subjects at high risk	5R01CA255515-05	Malgorzata Wojtowicz, M.D.
Yilmaz, Omer	Massachusetts Institute Of Technology United States	PROSPECT - Stem cell models	3OT2CA297570-01S1	Asad Umar, D.V.M., Ph.D.
You, Ming	Methodist Hospital Research Institute United States	Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis	5R01CA280746-02	John Clifford, Ph.D.